The clinical application of Zhengqing Fengqinning Delayed-Release Tablets is to treat rheumatism, rheumatoid arthritis belonging to the wind-cold-damp paralytic syndrome, as well as ordinary chronic nephritis belonging to the dampness stasis obstruction. Zhengqing Fengqinning Delayed-Release Tablets is a proprietary Chinese medicine, which is composed of cymbopogonin hydrochloride. It has the efficacy of dispelling wind and removing dampness (dispelling wind and dampness in the body), activating blood circulation, inducing diuresis and eliminating edema (facilitating urination and eliminating edema). It is used for rheumatism, rheumatoid arthritis belonging to wind-cold-damp paralytic syndrome, which can be seen as muscle pain, joint pain, numbness and stiffness. This drug can also be used in common type chronic nephritis belonging to dampness and stasis syndrome, which can be seen as edema, limb heaviness (limb weakness, heaviness), and urinary symptoms. A few patients have side effects such as leukopenia after taking the drug, which should be stopped immediately. Contraindicated in pregnant and lactating women; contraindicated in asthma; contraindicated in allergy to the product. It should be used with caution in people with a history of gastric disease. During the use of the drug, the blood test should be regularly rechecked. If rash occurs can reduce the dosage or stop the drug. It is not suitable to be used in combination with the preparations such as Huangqi, Lei Gonggen, White Peony Total Glycosides and so on. If there is a need for medication, it should be used under the guidance of a doctor, and should not be used blindly, so as to avoid adverse consequences.